Vesugen

Vesugen (T-38) is a tripeptide with the sequence KED or Lys-Glu-Asp. It is one of a number of small peptides developed in Russia in the late 1990s and early 2000s^[1] which are purported to have anti-aging effects.^[2][3] Vesugen is claimed to stimulate proliferation and protein synthesis in fibroblast cells in the skin and to improve the appearance of skin,^[4][5] as well as promoting neurotropic effects in brain tissue,^[6][7][8] giving it a similar pharmacological profile to those claimed for the matrikine peptides produced by Western cosmetic skincare companies.

CAS Number

• 204271-66-9

PubChem CID

• 87571363

ChemSpider

• 16572739

ChEBI

• CHEBI:159909

Quick facts Identifiers, CAS Number ...

Vesugen

Identifiers
IUPAC name (2S)-2-[[(2S)-4-carboxy-2-[[(2S)-2,6-diaminohexanoyl]amino]butanoyl]amino]butanedioic acid
CAS Number	204271-66-9
PubChem CID	87571363
ChemSpider	16572739
ChEBI	CHEBI:159909
Chemical and physical data
Formula	C15H26N4O8
Molar mass	390.393 g·mol−1
3D model (JSmol)	Interactive image
SMILES C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N
InChI InChI=1S/C15H26N4O8/c16-6-2-1-3-8(17)13(24)18-9(4-5-11(20)21)14(25)19-10(15(26)27)7-12(22)23/h8-10H,1-7,16-17H2,(H,18,24)(H,19,25)(H,20,21)(H,22,23)(H,26,27)/t8-,9-,10-/m0/s1 Key:LLSUNJYOSCOOEB-GUBZILKMSA-N

Close